BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) shares rose 1.8% during mid-day trading on Monday . The stock traded as high as $0.2076 and last traded at $0.2070. 15,530 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 174,831 shares. The stock had previously closed at $0.2033.
BetterLife Pharma Trading Up 24.7%
The firm has a 50-day moving average price of $0.15 and a two-hundred day moving average price of $0.08.
BetterLife Pharma Company Profile
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders.
Recommended Stories
- Five stocks we like better than BetterLife Pharma
- Speed Sells: Cerebras Cracks the Silicon Ceiling
- Amid Legal Risks, This Company Is Still Rated a Buy
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
